8-KThe WireRed Alert
Executive Change
Filed Mar 4, 2024 · 2y ago · Accession 0001193125-24-056937
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Mar 4, 2024
- Report date
- Mar 4, 2024
- Document
- d791106d8k.htm
- Size
- 174 KB